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Abstract
Background: The incidence, mortality, and prevalence of stroke are high in China. Stroke is commonly associated
with insomnia; both insomnia and stroke have been effectively treated with acupuncture for a long time. The aim
of this proposed trial is to assess the therapeutic effect of acupuncture on insomnia following stroke.
Methods: This proposed study is a single-center, single-blinded (patient-assessor-blinded), parallel-group
randomized controlled trial. We will randomly assign 60 participants with insomnia following stroke into
two groups in a 1:1 ratio. The intervention group will undergo traditional acupuncture that achieves the
De-qi sensation, and the control group will receive sham acupuncture without needle insertion. The same
acupoints (DU20, DU24, EX-HN3, EX-HN22, HT7, and SP6) will be used in both groups. Treatments will be
given to all participants three times a week for the subsequent 4 weeks. The primary outcome will be the
Pittsburgh Sleep Quality Index. The secondary outcomes will be: the Insomnia Severity Index; sleep efficacy,
sleep awakenings, and total sleep time recorded via actigraphy; the National Institutes of Health Stroke Scale; the
Stroke-Specific Quality of Life score; the Hospital Anxiety and Depression Scale. The use of estazolam will be permitted
and regulated under certain conditions. Outcomes will be assessed at baseline, 2 weeks after treatment commencement,
4 weeks after treatment commencement, and at the 8-week follow-up.
Discussion: This proposed study will contribute to expanding knowledge about acupuncture treatment for insomnia
following stroke. This will be a high-quality randomized controlled trial with strict methodology and few design deficits.
It will investigate the effectiveness of acupuncture as an alternative treatment for insomnia following stroke.
Trial registration: Chinese Clinical Trial Registry identifier: ChiCTR-IIC-16008382. Registered on 28 April 2016.
Keywords: Acupuncture, Insomnia, Stroke, Randomized controlled trial
Background
The Global Burden of Disease Study (2013) found that
cerebrovascular disease was the third leading cause of
disability-adjusted life years worldwide [1]. Cerebrovas-
cular disease is a major chronic disease in China, ranked
third among the most common causes of death for
urban residents and first for rural residents [2]. Stroke
morbidity in China is 89.6–314 out of every 100,000 in
men and 76.7–212.2 out of every 100,000 in women [3].
Stroke can be divided into two major types based on the
type of pathological process: hemorrhagic stroke and is-
chemic stroke. The incidence of hemorrhagic stroke in
China declined by 1.7% over a recent 21-year period, but
that of ischemic stroke increased by 8.7% annually [4].
Common post-stroke complications include sleep disor-
ders (SD), such as insomnia, sleep apnea, and daytime
sleepiness [5], and SD continues to be the most
unrecognized modifiable risk factor for stroke [6].
Untreated SD causes cognitive dysfunction, altered mood,
sleepiness, and fatigue, and may impede stroke rehabilita-
tion, lengthen hospital stay, influence stroke outcomes,
and increase the possibility of stroke recurrence [7].
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One of the most common SD associated with stroke is
insomnia [5]. Insomnia is characterized by difficulty in
falling asleep and staying asleep, early morning awakening,
and nonrestorative sleep. The primary pharmacological
treatments for insomnia are benzodiazepines, nonbenzo-
diazepine sedatives, and melatonin agonists. Although ef-
fective pharmacologic treatments for insomnia are
available, these medications often cause side effects such
as residual daytime sedation, drowsiness, dizziness, light-
headedness, cognitive impairment, motor incoordination,
and dependence [8]. The mainstay of nonpharmacologic
intervention for insomnia is cognitive behavioral therapy
(CBT). However, CBT often causes an acute reduction in
total sleep time (TST) during the first few weeks of treat-
ment, which means that SD improvements with CBT
require long-term implementation [9].
Faced with the limitations of currently available insom-
nia treatments, more people are seeking complementary
and alternative medicine options. According to the
theory of traditional Chinese medicine, acupuncture
provides overall coordination to help the body achieve a
state of relative equilibrium of yin and yang, restoring its
physiological function and regulating the sleep-awake
cycle. Recently, the frequency of visits to acupuncturists
has markedly increased in the United States [10];
however, there has been little focus on research into
acupuncture for insomnia following stroke. Two recent
randomized controlled trials (RCTs) had shown that
insomnia following stroke was positively affected by
intradermal acupuncture and low-frequency electric
stimulation at acupoints [11, 12]. However, these RCTs
had methodological deficits, including problems with
randomization, lack of sample size estimation, blinding
issues, no mention of acupuncturist certification, and no
use of the intention-to-treat (ITT) analysis [13]. These
design deficits make their findings far from conclusive.
More high-quality clinical RCTs are required to investi-
gate the effectiveness of acupuncture treatment for
insomnia following stroke. In this proposed RCT, we




1. Participants with insomnia following stroke
treated with real acupuncture will have greater
improvement in sleep quality and other related
symptoms than those treated with sham
acupuncture
2. The sham acupuncture procedure can be
successfully implemented in this RCT in
which participants will be unaware of the
group assignment
Objectives
1. To compare improvement in sleep quality recorded
using the Pittsburgh Sleep Quality Index (PSQI)
between the intervention group and control group
2. To compare changes between the intervention group
and control group in the Insomnia Severity Index
(ISI), actigraphy, the National Institutes of Health
Stroke Scale (NIHSS), the Stroke-Specific Quality of
Life (SS-QOL), and the Hospital Anxiety and De-
pression Scale (HADS)
3. To evaluate the design of the sham acupuncture
procedure
Design
This is a single-center, patient-assessor-blinded, parallel-
group RCT that conforms to the Consolidated Standards
of Reporting Trials [14] and Standards for Reporting
Interventions in Clinical Trials of Acupuncture [15]
guidelines for acupuncture studies. Eligible patients will
be randomly divided into the intervention group and the
control group in a 1:1 allocation ratio.
The flowchart of the study process is detailed in Fig. 1.
The timing of treatment visits and data collection is de-
tailed in Table 1.
Recruitment
All participants will be recruited through advertisements
on micromessage (Wechat) and hospital bulletin boards
in Shanghai Municipal Hospital of Traditional Chinese
Medicine in Shanghai, China. If they show interest in
participating, they can call the researchers with the
phone number reserved. The researcher in charge of
recruitment will explain the study in detail, and outline
the potential benefits of this RCT to patients with in-
somnia following stroke. Patients who show interest in
participating will be assessed according to the inclusion
and exclusion criteria on their first visit. Once they agree
to participate in this RCT, they will be asked to sign
written informed consent before undergoing acupunc-
ture intervention.
Participants
Inclusion criteria: men or women aged 18–75 years who
(1) meet the diagnostic criteria of ischemic stroke ac-
cording to the guidelines for the diagnosis and treatment
of acute ischemic stroke in China (2014) [16] in the past
2 weeks to 2 years, (2) meet the diagnostic criteria of
insomnia according to the Diagnostic and Statistical
Manual of Mental Disorders, Fifth Edition [17] for at
least 1 month, (3) PSQI score ≥ 6, (4) ISI score ≥ 8, (5)
demonstrate no problems with communication, both
visual and auditory (reading, writing, hearing, speaking,
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and seeing), and (6) sign a written informed consent for
participation in the RCT.
Exclusion criteria: (1) those who have experienced in-
somnia before their stroke, (2) a history of sleep apnea
syndrome, (3) a history of severe neural or psychiatric
disorder or major neuropsychiatric disorder (such as
autism, learning disorder, or mental retardation), (4)
severe primary disease of the cardiovascular, hepatic,
renal, or hematopoietic system, (5) infection or inflam-
mation at the acupoints, (6) hemorrhagic disease or anti-
coagulant intake, (7) those who have used Western and/
or Oriental medicine in the past 2 weeks for depression,
or anxiety, (8) those who have received acupuncture for
insomnia in the past month, (9) those who have partici-
pated in any other clinical trial in the past 3 months,
(10) those who are pregnant or breastfeeding, and
women of childbearing age who are not using proper
birth control, and (11) refusal to wear a wristwatch-like
actigraph while sleeping.
Dropout criteria: (1) development of serious disease
(such as heart disease, pneumonia, or stroke) during the
observation period, (2) receiving other treatments for in-
somnia (such as other Western medicine, Oriental
medicine, moxibustion, or massage) during the observa-
tion period, (3) participants who present with serious
adverse events, (4) participants who refuse to con-
tinue to participate in the RCT, and (5) those lost to
follow-up.
Intervention
The participants from outpatient departments will
receive acupuncture treatments in the outpatient clinic
of the acupuncture department three times per week for
4 weeks. The inpatients will receive acupuncture treat-
ment three times per week at the time of hospitalization,
and will then receive outpatient treatment three times
per week for 2 weeks. In each treatment session, every
patient will be placed in a separate quiet space and asked
to wear an eye-patch. Each treatment session will be
20 min. The treatment course will last for 4 weeks, and
the follow-up period will be 4 weeks. All participants
will receive standard Western medicine therapy for
stroke, limb function rehabilitation therapy, and clinical
nursing in Shanghai Municipal Hospital of Traditional
Chinese Medicine. To improve adherence to interven-
tion protocols, all participants will receive intervention
and assessments by telephone reservations, and be given
some financial subsidies after follow-up.
Patients in both groups will be treated with stain-
less steel needles (0.25 × 25 mm and 0.30 × 40 mm;
Wuxi Jiajian Medical Material Co., Ltd., Wuxi, China)
at the same acupoints, including Baihui (DU20),
Shenting (DU24), Yintang (EX-HN3), bilateral Anmian
Fig. 1 Study process
Table 1 Timing of treatment visits and data collection
Baseline Treatment phase Follow-up
phase
Week 0 Week 2 Week 4 Week 8
Sign informed consent ×
Medical history ×
Randomization ×
Intervention × × ×
Primary outcome
PSQI × × ×
Secondary outcomes
ISI × × × ×
Actigraphy × × × ×
NIHSS × × × ×
SS-QOL × × × ×
HADS × × × ×
Estazolam dose × × ×
Adverse events × × ×
HADS Hospital Anxiety and Depression Scale, ISI Insomnia Severity Index,
NIHSS National Institutes of Health Stroke Scale, PSQI Pittsburgh Sleep Quality
Index, SS-QOL Stroke-Specific Quality of Life
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(EX-HN22), bilateral Shenmen (HT7), and bilateral
Sanyinjiao (SP6). The acupuncturist will use 0.25 ×
25-mm needles for acupoints DU20, DU24, EX-HN3
and HT7, and 0.30 × 40-mm needles for acupoints
EX-HN22 and SP6 (Table 2).
The intervention group
The intervention group will be treated with the real
tube-needling method, while lying in the supine position
and wearing an eye-patch. After routine skin sterilizing,
DU20, DU24, and EX-HN3 will be punctured obliquely
10 mm deep into the skin; EX-HN22 and SP6 will be
punctured 15 mm deep in a direction perpendicular to
the skin, and HT7 will be punctured perpendicularly to
a depth of 5 mm. Licensed and experienced acupunctur-
ists will conduct needle manipulation including lifting,
thrusting, and rotating to obtain the proper needling
sensation (De-qi sensation). Then they will stick a 2 × 2-
cm piece of tape on the skin beside each needle. After a
20-min retention period, the needles and tapes will be
removed simultaneously.
The control group
The control group will receive sham acupuncture treat-
ment. Before each session of sham acupuncture, we will
prepare plastic tubes with a blunt needle inside each
one. The acupuncturist will put the tube needle-end-up
on the skin, and knock the tube slightly. The needles
with blunt tips will not be inserted into the skin, but will
create a pricking sensation similar to real acupunc-
ture. After removing the tubes, the blunt needles will
be stuck at the acupoints with 2 × 2-cm pieces of
tape. After a 20-min retention period, the needles and
tapes will be removed simultaneously.
Outcomes
Primary outcomes
The primary outcomes of this study will be the changes
in the PSQI between baseline, 4 weeks after treatment
commencement, and the 8-week follow-up. All question-
naires will be in Chinese.
 Pittsburgh Sleep Quality Index
The PSQI is a self-rated questionnaire used
to assess sleep quality and disturbances over
a 1-month period. It comprises 19 self-rated
items and five other-rated items [18]. The
scores for the 19 self-rated items and five
other-rated items are not included in the total
score. Except for the first item, the remaining
18 items include the seven following subscales:
subjective sleep quality, sleep latency, sleep
duration, habitual sleep efficacy (SE), sleep
disturbances, use of sleeping medication, and
daytime dysfunction. Each subscale is rated from 0
to 3, and the accumulated scores of the seven sub-
scales constitute the total score of the PSQI (0–21).
A higher score indicates a more severe SD.
Secondary outcomes
 Secondary outcomes refer to the ISI score, the
NIHSS score, the SS-QOL, the HADS, and the
dose of estazolam during the 8-week trial at baseline,
2 weeks after treatment commencement, 4 weeks
after treatment commencement, and the 8-week
follow-up. All questionnaires will be presented in
Chinese
 Insomnia Severity Index
The ISI is a Likert 5-point self-rated questionnaire
designed to assess the nature, severity, and impact
of insomnia. It includes seven items, with the
sum score ranging from 0 to 28 [19]. A higher
score suggests more severe sleep disturbance.
ISI categories are: clinically significant insomnia
(score 0–7), subthreshold insomnia (score 8–14),
moderate clinical insomnia (score 15–21), and
severe clinical insomnia (score 22–28)
Table 2 Details of interventions
Intervention group Control group
Acupoints DU20, DU24, EX-HN3, EX-HN22, HT7, SP6 DU20, DU24, EX-HN3, EX-HN22, HT7, SP6
Depth of needle insertion DU20, DU24, EX-HN3: 10 mm No needle insertion
EX-HN22, SP6: 15 mm
HT7: 5 mm
Needle retention time 20 min 20 min
Needle type Stainless steel Blunt stainless steel
(0.25 × 25 mm or 0.30 × 4 0 mm; Wuxi Jiajian,
Wuxi, China)
(0.25 × 25 mm or 0.30 × 40 mm; Wuxi Jiajian,
Wuxi, China)
Frequency and duration of treatment sessions Three times a week for the subsequent 4 weeks Three times a week for the subsequent 4 weeks
Needle stimulation De-qi sensation Without De-qi sensation
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 Actigraphy
The wActiSleep-BT actigraph (Actigraph LLC,
Pensacola, FL, USA) is a noninvasive, small,
wristwatch-like device that will be worn on
the patient’s nondominant wrist. Patients
will be instructed to wear the actigraph for
two consecutive nights before each
assessment time point. The patients’ motion
will be recorded in 1-min epochs during
sleep and stored continuously as data of SE,
sleep awakenings, and TST. The analysis of
sleep quality will be performed by dedicated
ActiLife 6 data analysis software (ActiGraph
LLC)
 National Institutes of Health Stroke Scale
The NIHSS is a stroke-specific quantitative
scale used to assess neurological deficits in
terms of consciousness, eye movements,
visual fields, facial palsy, motor and sensory
impairments, ataxia, language function, and
neglect. A higher score indicates a more
severe neurological deficit [20]. Each
participant will be assessed by a trained,
certified investigator at baseline, 2 weeks
after treatment commencement, 4 weeks after
treatment commencement, and at the 8-week
follow-up
 Stroke-Specific Quality of Life
The SS-QOL is used to assess the health-related
quality of life of stroke patients in the past week
[21]. The SS-QOL consists of 49 items, with 12
domains of energy, family roles, language, mobility,
mood, personality, self-care, social roles,
thinking, upper extremity function, vision,
and work/productivity. The total score is the
sum of the 12 domain scores. A higher score
indicates better function
 Hospital Anxiety and Depression Scale
The HADS is a validated, widely-used, 14-item
self-report scale designed to briefly measure
current anxiety and depressive symptoms in
nonpsychiatric hospital patients [22]. It excludes
somatic symptoms, therefore avoiding potential
confounding factors. The HADS comprises two
independent seven-item subscales for anxiety and
depression
 Estazolam dose
Throughout this RCT, participants will be
allowed to take 0.5–2 mg estazolam when they
experience difficulty falling asleep for more
than two consecutive days, or when they feel
seriously ill because of insomnia symptoms.
The dose should be recorded in the
paper
Sample size
The sample size calculation for our RCT is based on the
change in the PSQI score. According to previous re-
search [23], a sample size of 24 participants should be
recruited in each group. Assuming about a 20% dropout
rate, we estimate that a total of 60 participants should
be recruited for this RCT.
Randomization
We plan to use the random block method. An independ-
ent researcher, who has no contact with any participant,
will use SPSS version 23.0 software (SPSS Inc., Chicago,
IL, USA) to generate a random number table to divide
the eligible participants in a 1:1 ratio into the interven-
tion group and the control group. The random alloca-
tion sequence will be generated in a block of 3. The
researcher will then make random allocation cards and
seal each card in an opaque envelope whose number is
the same as the number on the card. According to the
time order in which patients are asked to go to the hos-
pital, another researcher will arrange the patients into
different groups and inform the acupuncturists of the
group assignment.
Blinding method
This is a single-blinded (patient-assessor-blinded) study.
Participants will be asked to wear an eye-patch in a
separate quiet space before treatment, and will remain
blinded during the whole treatment. Except for the acu-
puncturists, all other researchers (including the statisti-
cians, outcome assessors, and data analysts) will be
blinded to the group assignment. We will attempt to
validate the successful implementation of the blinding
method. At first treatment, all patients will be told that
the needling sensation that they are experiencing is the
real sensation of acupuncture. In addition, all re-
searchers will undergo training on the specifications of
this RCT before commencement, and will strictly adhere
to the separation principle of each department. The pri-
mary blinding method was successfully implemented by
Lao et al. [24] in a trial to evaluate the efficacy of acu-
puncture treatment for postoperative oral surgery pain.
We used this report as a reference to improve the design
of our RCT and to ensure successful completion.
Safety assessment
Participants will be asked to report any adverse event
or related information after acupuncture treatment.
The detail of every adverse event will be measured by
Dr. Francisca Soto-Aguilar and reported in the Case
Report Form. Adverse events include any unfavorable
or unintended signs, symptoms, or diseases occurring
during the whole RCT.
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Statistical analysis
All data will be analyzed according to the ITT principle
to reduce deviation. The Student’s t test will be used to
compare differences in measurement data. The rank
sum test will be used to deal with ranked data, and the
chi-squared test will be used to analyze categorical data.
Analyses will be performed with SPSS version 23.0
software (SPSS Inc., Chicago, IL, USA).
Monitoring
To guarantee the quality of this RCT, it will be
carried out by Shanghai Municipal Hospital of Trad-
itional Chinese Medicine. We will promptly input
data from this RCT on the ResMan website at http://
www.chictr.org.cn/index.aspx. As the Data Monitoring
Team to identify problems in the project, examine
collected data, and control bias, The Clinical Research
Center of Drugs of the Shanghai University of Trad-
itional Chinese Medicine will have access to these
interim results and make the final decision to termin-
ate the trial. A qualified clinical trial expert will be
invited to monitor this RCT.
Clinical trial registration
We applied for registration of this RCT in the Chinese
Clinical Trial Registry. This will reduce all kinds of bias
in clinical research, increase the transparency of trials,
ensure the high quality of clinical trials and test
processes, and the credibility of results.
Discussion
Acupuncture treatment has been widely used to reduce
the symptoms of insomnia [25]. There is minimal theor-
etical research or clinical RCTs on acupuncture for
insomnia following stroke. This RCT will investigate the
effectiveness of acupuncture in reducing insomnia
following stroke. We are attempting to conduct a
clinical RCT with adequate design and few deficits.
We designed the sham acupuncture method without
needle insertion to assess the specific effects of acu-
puncture rather than its placebo effect for treating in-
somnia following stroke. Furthermore, in contrast to
the subjective assessments made in most trials, we
will use actigraphy in our RCT to objectively assess
the physiological changes in patients with insomnia.
We will use the ITT principle to handle statistical
data to reduce deviation of the RCT.
There are some inevitable limitations in this RCT.
For example, it is hard to make the RCT double-
blinded. The participants, the assessor, and the stat-
istical expert will be blinded to the group assign-
ment in this RCT; however, it will be impossible to
blind the acupuncturist. This RCT is also restricted
to a single-center hospital. Furthermore, although
actigraphy is suitable for measuring nocturnal rest-
lessness, it cannot differentiate between sleep stages
or score rapid eye movement sleep, which may have
helped to explain the mechanism of acupuncture for
treating insomnia following stroke. In further studies,
we may consider a multicenter clinical trial, using
polysomnography as an assessment method.
Trial status
We started recruiting participants in July 2016.
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